123 related articles for article (PubMed ID: 37897328)
1. Construction and Mechanism of IL-15-Based Coactivated Polymeric Micelles for NK Cell Immunotherapy.
Shao D; Bai T; Zhu B; Guo X; Dong K; Shi J; Huang Q; Kong J
Adv Healthc Mater; 2024 Feb; 13(4):e2302589. PubMed ID: 37897328
[TBL] [Abstract][Full Text] [Related]
2. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
Front Immunol; 2018; 9():3169. PubMed ID: 30761160
[No Abstract] [Full Text] [Related]
3. Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function.
Manzini C; Venè R; Cossu I; Gualco M; Zupo S; Dono M; Spagnolo F; Queirolo P; Moretta L; Mingari MC; Pietra G
Oncotarget; 2016 Sep; 7(38):60858-60871. PubMed ID: 27563819
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.
Anguille S; Van Acker HH; Van den Bergh J; Willemen Y; Goossens H; Van Tendeloo VF; Smits EL; Berneman ZN; Lion E
PLoS One; 2015; 10(5):e0123340. PubMed ID: 25951230
[TBL] [Abstract][Full Text] [Related]
5. A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity.
Xiong Q; Zhang H; Ji X; Zhang Y; Shi G; Dai L; Cheng F; Wang H; Luo J; Xu J; Ji Y; Su X; Yang W; Zhang L; Deng H
Oncoimmunology; 2022; 11(1):2127282. PubMed ID: 36185809
[TBL] [Abstract][Full Text] [Related]
6. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.
Mao Y; van Hoef V; Zhang X; Wennerberg E; Lorent J; Witt K; Masvidal L; Liang S; Murray S; Larsson O; Kiessling R; Lundqvist A
Blood; 2016 Sep; 128(11):1475-89. PubMed ID: 27465917
[TBL] [Abstract][Full Text] [Related]
7. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
[TBL] [Abstract][Full Text] [Related]
9. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
[TBL] [Abstract][Full Text] [Related]
10. Use of interleukin-15 for preparation of adherent NK cells from human peripheral blood: comparison with interleukin-2.
Sun R; Fan J; Wei H; Zhang C; Tian Z
J Immunol Methods; 2003 Aug; 279(1-2):79-90. PubMed ID: 12969549
[TBL] [Abstract][Full Text] [Related]
11. Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy.
Ma S; Caligiuri MA; Yu J
Trends Immunol; 2022 Oct; 43(10):833-847. PubMed ID: 36058806
[TBL] [Abstract][Full Text] [Related]
12. Short-term IL-15 priming leaves a long-lasting signalling imprint in mouse NK cells independently of a metabolic switch.
Luu TT; Schmied L; Nguyen NA; Wiel C; Meinke S; Mohammad DK; Bergö M; Alici E; Kadri N; Ganesan S; Höglund P
Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33593878
[TBL] [Abstract][Full Text] [Related]
13. Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15.
Imamura M; Shook D; Kamiya T; Shimasaki N; Chai SM; Coustan-Smith E; Imai C; Campana D
Blood; 2014 Aug; 124(7):1081-8. PubMed ID: 25006133
[TBL] [Abstract][Full Text] [Related]
14. Suspension culture promoted the expansion of NK-92 cells ex vivo by enhancing the expression of IL-2 receptor.
Huang H; Zhang S; Zhao Y; Xu R; Tan WS; Cai H
Biotechnol J; 2024 Mar; 19(3):e2300654. PubMed ID: 38472089
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2
Chu Y; Nayyar G; Jiang S; Rosenblum JM; Soon-Shiong P; Safrit JT; Lee DA; Cairo MS
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34244307
[TBL] [Abstract][Full Text] [Related]
16. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.
Christodoulou I; Ho WJ; Marple A; Ravich JW; Tam A; Rahnama R; Fearnow A; Rietberg C; Yanik S; Solomou EE; Varadhan R; Koldobskiy MA; Bonifant CL
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34896980
[TBL] [Abstract][Full Text] [Related]
17. Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells.
Chan A; Filer A; Parsonage G; Kollnberger S; Gundle R; Buckley CD; Bowness P
Arthritis Rheum; 2008 Mar; 58(3):707-17. PubMed ID: 18311795
[TBL] [Abstract][Full Text] [Related]
18. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
Wittnebel S; Da Rocha S; Giron-Michel J; Jalil A; Opolon P; Escudier B; Validire P; Khawam K; Chouaib S; Azzarone B; Caignard A
Cancer Res; 2007 Jun; 67(12):5594-9. PubMed ID: 17575122
[TBL] [Abstract][Full Text] [Related]
19. Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.
Bluman EM; Bartynski KJ; Avalos BR; Caligiuri MA
J Clin Invest; 1996 Jun; 97(12):2722-7. PubMed ID: 8675682
[TBL] [Abstract][Full Text] [Related]
20. Cytokine regulation of natural killer cell effector functions.
Zwirner NW; Domaica CI
Biofactors; 2010; 36(4):274-88. PubMed ID: 20623510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
